ACCESS PACK EXPO XPRESS ONLINE TODAY
ACCESS PACK EXPO XPRESS ONLINE TODAY. Content is available on-demand through November 30th.
LEARN MORE

Clinical Trial Finds Lyme Disease Vaccine Safe and Effective

The new vaccine could be available as soon as 2025.

A recent Precisions Vaccinations article discussed a new vaccine that can prevent the tick-transmitted disease that can cause permanent damage to joints and nerves. The Lyme disease vaccine, developed by Valneva, works by stopping Lyme-causing bacteria in ticks from penetrating the bloodstream. 

A press statement published on July 22nd noted the VLA15 vaccine candidate proved immunogenic across all groups tested. Furthermore, higher doses elicited high antibody responses across all groups as well. Valneva is working with Pfizer to develop and commercialize the vaccine, which should be available within 5 years.

Access On-Demand Content Today
Discover innovative solutions for packaging and processing, automation, sustainability, e-commerce and more.
LEARN MORE
Access On-Demand Content Today
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub